$ARQ
Arq, Inc. Stock $arq

$arq Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000151515616000143 Filed on August 09, 2016

Income Statement

Concept	2016 Q2	2015 Q2
Revenue	$8.951M	$14.90M
YoY Change	-39.91%	369.13%
Cost Of Revenue	$5.769M	$14.00M
YoY Change	-58.8%	698.35%
Gross Profit	$3.182M	$892.0K
YoY Change	256.73%	-37.23%
Gross Profit Margin	35.55%	5.99%
Selling, General & Admin	$7.930M	$16.24M
YoY Change	-51.17%	79.05%
% of Gross Profit	249.21%	1820.63%
Research & Development	-$345.0K	$1.860M
YoY Change	-118.55%	488.61%
% of Gross Profit	-10.84%	208.52%
Depreciation & Amortization	$220.0K	$570.0K
YoY Change	-61.4%	26.67%
% of Gross Profit	6.91%	63.9%
Operating Expenses	$13.56M	$32.67M
YoY Change	-58.49%	181.81%
Operating Profit	-$4.612M	-$17.78M
YoY Change	-74.06%	111.14%
Interest Expense	$1.573M	$1.794M
YoY Change	-12.32%	47.17%
% of Operating Profit
Other Income/Expense, Net	$12.57M	$5.394M
YoY Change	133.06%	-42.87%
Pretax Income	$7.959M	-$12.38M
YoY Change	-164.27%	-1312.93%
Income Tax	$99.00K	$63.00K
% Of Pretax Income	1.24%
Net Earnings	$7.860M	-$12.45M
YoY Change	-163.15%	-1354.74%
Net Earnings / Revenue	87.81%	-83.56%
Basic Earnings Per Share	$0.36	-$0.57
Diluted Earnings Per Share	$0.35	-$0.57
COMMON SHARES
Basic Shares Outstanding	21.88M shares	21.72M shares
Diluted Shares Outstanding	22.19M shares	21.72M shares

Balance Sheet

Concept	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.500M	$10.40M
YoY Change	-75.96%
Cash & Equivalents	$2.221M	$10.41M
Short-Term Investments	$300.0K
Other Short-Term Assets	$1.781M	$12.10M
YoY Change	-85.28%
Inventory	$187.0K
Prepaid Expenses	$1.287M
Receivables	$8.950M	$9.218M
Other Receivables	$400.0K	$1.700M
Total Short-Term Assets	$19.12M	$33.36M
YoY Change	-42.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.218M	$4.076M
YoY Change	-70.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.081M	$20.24M
YoY Change	-84.78%
Other Assets	$3.714M	$15.70M
YoY Change	-76.34%
Total Long-Term Assets	$17.49M	$43.14M
YoY Change	-59.46%
TOTAL ASSETS
Total Short-Term Assets	$19.12M	$33.36M
Total Long-Term Assets	$17.49M	$43.14M
Total Assets	$36.61M	$76.50M
YoY Change	-52.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.263M	$10.23M
YoY Change	-68.09%
Accrued Expenses	$5.400M	$7.300M
YoY Change	-26.03%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$1.600M
YoY Change	-100.0%
Total Short-Term Liabilities	$30.27M	$48.01M
YoY Change	-36.96%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$13.70M
YoY Change	-100.0%
Other Long-Term Liabilities	$2.871M	$6.053M
YoY Change	-52.57%
Total Long-Term Liabilities	$2.871M	$6.053M
YoY Change	-52.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.27M	$48.01M
Total Long-Term Liabilities	$2.871M	$6.053M
Total Liabilities	$47.10M	$91.09M
YoY Change	-48.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$128.8M	-$129.5M
YoY Change	-0.52%
Common Stock	$22.00K	$22.00K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.49M	-$14.60M
YoY Change
Total Liabilities & Shareholders Equity	$36.61M	$76.50M
YoY Change	-52.14%

Cashflow Statement

Concept	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	$7.860M	-$12.45M
YoY Change	-163.15%	-1354.74%
Depreciation, Depletion And Amortization	$220.0K	$570.0K
YoY Change	-61.4%	26.67%
Cash From Operating Activities	-$6.990M	-$5.580M
YoY Change	25.27%	-47.11%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$270.0K
YoY Change	-96.3%	-25.0%
Acquisitions
YoY Change
Other Investing Activities	$14.87M	$4.870M
YoY Change	205.34%	-49.27%
Cash From Investing Activities	$14.86M	$4.600M
YoY Change	223.04%	-50.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.73M	-350.0K
YoY Change	3251.43%
NET CHANGE
Cash From Operating Activities	-6.990M	-5.580M
Cash From Investing Activities	14.86M	4.600M
Cash From Financing Activities	-11.73M	-350.0K
Net Change In Cash	-3.860M	-1.330M
YoY Change	190.23%	1.53%
FREE CASH FLOW
Cash From Operating Activities	-$6.990M	-$5.580M
Capital Expenditures	-$10.00K	-$270.0K
Free Cash Flow	-$6.980M	-$5.310M
YoY Change	31.45%	-47.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	ades	Accrued Interest Current AccruedInterestCurrent	1042000	USD
CY2016Q2	ades	Accrued Interest Current AccruedInterestCurrent	1483000	USD
CY2015Q4	ades	Accrued Losseson Equipment Contracts Current AccruedLossesonEquipmentContractsCurrent	759000	USD
CY2016Q2	ades	Accrued Losseson Equipment Contracts Current AccruedLossesonEquipmentContractsCurrent	550000	USD
CY2016Q2	ades	Concentrationof Credit Risk Numberof Financial Institutionswith Certificatesof Deposit Investments ConcentrationofCreditRiskNumberofFinancialInstitutionswithCertificatesofDepositInvestments	2	Financial_Institution
	ades	Cost Incurred On Uncompleted Contracts CostIncurredOnUncompletedContracts	2363000	USD
	ades	Cost Incurred On Uncompleted Contracts CostIncurredOnUncompletedContracts	17201000	USD
CY2015Q4	ades	Deferred Revenue Related Party DeferredRevenueRelatedParty	2000000	USD
CY2016Q2	ades	Deferred Revenue Related Party DeferredRevenueRelatedParty	2000000	USD
	ades	Gain Losson Settlementof Note Payableand Licensed Technology GainLossonSettlementofNotePayableandLicensedTechnology	0	USD
	ades	Gain Losson Settlementof Note Payableand Licensed Technology GainLossonSettlementofNotePayableandLicensedTechnology	1019000	USD
	ades	Increase Decrease In Settlement Awards And Related Accrued Liabilities IncreaseDecreaseInSettlementAwardsAndRelatedAccruedLiabilities	-1472000	USD
	ades	Increase Decrease In Settlement Awards And Related Accrued Liabilities IncreaseDecreaseInSettlementAwardsAndRelatedAccruedLiabilities	2767000	USD
	ades	Increase Decrease Interest On Notes Payable IncreaseDecreaseInterestOnNotesPayable	432000	USD
	ades	Increase Decrease Interest On Notes Payable IncreaseDecreaseInterestOnNotesPayable	0	USD
	ades	Increase Decreasein Working Capital IncreaseDecreaseinWorkingCapital	14200000	USD
CY2015Q2	ades	Interest Expense453 A InterestExpense453A	1116000	USD
	ades	Interest Expense453 A InterestExpense453A	2272000	USD
CY2016Q2	ades	Interest Expense453 A InterestExpense453A	354000	USD
	ades	Interest Expense453 A InterestExpense453A	1145000	USD
CY2015Q2	ades	Interest Expense Debt Related Party InterestExpenseDebtRelatedParty	609000	USD
	ades	Interest Expense Debt Related Party InterestExpenseDebtRelatedParty	1214000	USD
CY2016Q2	ades	Interest Expense Debt Related Party InterestExpenseDebtRelatedParty	0	USD
	ades	Interest Expense Debt Related Party InterestExpenseDebtRelatedParty	263000	USD
CY2015Q4	ades	Legal Settlements LegalSettlements	0	USD
CY2016Q2	ades	Legal Settlements LegalSettlements	5125000	USD
CY2016Q2	ades	Loans Receivable Fixed Interest Rate LoansReceivableFixedInterestRate	0.08
CY2015Q4	ades	Other Assets Noncurrent Other OtherAssetsNoncurrentOther	341000	USD
CY2016Q2	ades	Other Assets Noncurrent Other OtherAssetsNoncurrentOther	321000	USD
CY2015Q4	ades	Other Liabilities Current Other OtherLiabilitiesCurrentOther	2825000	USD
CY2016Q2	ades	Other Liabilities Current Other OtherLiabilitiesCurrentOther	3132000	USD
	ades	Proceeds From Advanceson Note Receivables ProceedsFromAdvancesonNoteReceivables	500000	USD
	ades	Proceeds From Advanceson Note Receivables ProceedsFromAdvancesonNoteReceivables	0	USD
CY2015Q4	ades	Other Longterm Liabilities OtherLongtermLiabilities	2605000	USD
CY2016Q2	ades	Other Longterm Liabilities OtherLongtermLiabilities	266000	USD
CY2015Q2	ades	Restructuring Accrual Reversals RestructuringAccrualReversals	2000	USD
	ades	Restructuring Accrual Reversals RestructuringAccrualReversals	12000	USD
CY2016Q2	ades	Restructuring Accrual Reversals RestructuringAccrualReversals	0	USD
	ades	Restructuring Accrual Reversals RestructuringAccrualReversals	0	USD
CY2015Q4	ades	Settlement Awards And Indemnity Liability SettlementAwardsAndIndemnityLiability	20299000	USD
CY2016Q2	ades	Settlement Awards And Indemnity Liability SettlementAwardsAndIndemnityLiability	23066000	USD
CY2015Q4	ades	Settlement Awards And Indemnity Liability Noncurrent SettlementAwardsAndIndemnityLiabilityNoncurrent	13797000	USD
CY2016Q2	ades	Settlement Awards And Indemnity Liability Noncurrent SettlementAwardsAndIndemnityLiabilityNoncurrent	11596000	USD
CY2015Q4	ades	Settlement Awards And Related Accrued Liabilities Current SettlementAwardsAndRelatedAccruedLiabilitiesCurrent	6502000	USD
CY2016Q2	ades	Settlement Awards And Related Accrued Liabilities Current SettlementAwardsAndRelatedAccruedLiabilitiesCurrent	11470000	USD
CY2015Q4	ades	Settlementand Royalty Indemnification SettlementandRoyaltyIndemnification	6502000	USD
CY2016Q2	ades	Settlementand Royalty Indemnification SettlementandRoyaltyIndemnification	6345000	USD
CY2015Q4	ades	Settlementand Royalty Indemnificationlongterm SettlementandRoyaltyIndemnificationlongterm	13797000	USD
CY2016Q2	ades	Settlementand Royalty Indemnificationlongterm SettlementandRoyaltyIndemnificationlongterm	11596000	USD
CY2016Q2	ades	Time Deposits250000or More TimeDeposits250000orMore	250000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001515156
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22037821	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Advanced Emissions Solutions, Inc.
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6174000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3263000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8361000	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8950000	USD
CY2016Q2	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	1000000	USD
CY2015Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	1918000	USD
CY2016Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	444000	USD
CY2015Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	369000	USD
CY2016Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	0	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4557000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2528000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	116029000	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	118280000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4505000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5459000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	907000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1543000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	50000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1152000	USD
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	381000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	406000	shares
CY2016Q2	us-gaap	Capital Leases Lessor Balance Sheet Net Investment In Direct Financing And Sales Type Leases Current CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesCurrent	307000	USD
CY2015Q4	us-gaap	Capital Leases Lessor Balance Sheet Net Investment In Direct Financing And Sales Type Leases Noncurrent CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesNoncurrent	0	USD
CY2016Q2	us-gaap	Capital Leases Lessor Balance Sheet Net Investment In Direct Financing And Sales Type Leases Noncurrent CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesNoncurrent	2494000	USD
CY2016Q2	us-gaap	Capital Leases Net Investment In Sales Type Leases CapitalLeasesNetInvestmentInSalesTypeLeases	2801000	USD
CY2016Q2	us-gaap	Capital Leases Net Investment In Sales Type Leases Deferred Income CapitalLeasesNetInvestmentInSalesTypeLeasesDeferredIncome	2707000	USD
CY2016Q2	us-gaap	Capital Leases Net Investment In Sales Type Leases Minimum Payments To Be Received CapitalLeasesNetInvestmentInSalesTypeLeasesMinimumPaymentsToBeReceived	5508000	USD
CY2016Q2	us-gaap	Capital Leases Net Investment In Sales Type Leases Unguaranteed Residual Values Of Leased Property CapitalLeasesNetInvestmentInSalesTypeLeasesUnguaranteedResidualValuesOfLeasedProperty	0	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25181000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10413000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9265000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2221000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-14768000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	46000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	517000	USD
CY2014Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1188000	USD
CY2015Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1248000	USD
CY2016Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1279000	USD
CY2015	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	60000	USD
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	31000	USD
CY2015Q4	us-gaap	Assets Assets	60775000	USD
CY2016Q2	us-gaap	Assets Assets	36608000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	24715000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	19119000	USD
CY2015Q4	us-gaap	Billings In Excess Of Cost Current BillingsInExcessOfCostCurrent	9708000	USD
CY2016Q2	us-gaap	Billings In Excess Of Cost Current BillingsInExcessOfCostCurrent	5112000	USD
CY2016Q2	us-gaap	Capital Leases Future Minimum Payments Receivable CapitalLeasesFutureMinimumPaymentsReceivable	2801000	USD
CY2016Q2	us-gaap	Capital Leases Future Minimum Payments Receivable Due Thereafter CapitalLeasesFutureMinimumPaymentsReceivableDueThereafter	0	USD
CY2016Q2	us-gaap	Capital Leases Future Minimum Payments Receivable In Five Years CapitalLeasesFutureMinimumPaymentsReceivableInFiveYears	796000	USD
CY2016Q2	us-gaap	Capital Leases Future Minimum Payments Receivable In Four Years CapitalLeasesFutureMinimumPaymentsReceivableInFourYears	721000	USD
CY2016Q2	us-gaap	Capital Leases Future Minimum Payments Receivable In Three Years CapitalLeasesFutureMinimumPaymentsReceivableInThreeYears	536000	USD
CY2016Q2	us-gaap	Capital Leases Future Minimum Payments Receivable In Two Years CapitalLeasesFutureMinimumPaymentsReceivableInTwoYears	441000	USD
CY2016Q2	us-gaap	Capital Leases Future Minimum Payments Receivable Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear	307000	USD
CY2015Q4	us-gaap	Capital Leases Lessor Balance Sheet Net Investment In Direct Financing And Sales Type Leases Current CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesCurrent	0	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7044000	USD
CY2015Q2	us-gaap	Coal Products And Services Revenue CoalProductsAndServicesRevenue	14236000	USD
	us-gaap	Coal Products And Services Revenue CoalProductsAndServicesRevenue	35351000	USD
CY2016Q2	us-gaap	Coal Products And Services Revenue CoalProductsAndServicesRevenue	8213000	USD
	us-gaap	Coal Products And Services Revenue CoalProductsAndServicesRevenue	29919000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	454000	USD
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21943872	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22241474	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21809164	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21967969	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	22000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	22000	USD
CY2015Q2	us-gaap	Contract Revenue Cost ContractRevenueCost	264000	USD
	us-gaap	Contract Revenue Cost ContractRevenueCost	690000	USD
CY2016Q2	us-gaap	Contract Revenue Cost ContractRevenueCost	77000	USD
	us-gaap	Contract Revenue Cost ContractRevenueCost	212000	USD
CY2015Q4	us-gaap	Cost Method Investments CostMethodInvestments	2776000	USD
CY2016Q2	us-gaap	Cost Method Investments CostMethodInvestments	2776000	USD
CY2015Q2	us-gaap	Cost Of Coal Products And Services CostOfCoalProductsAndServices	13698000	USD
	us-gaap	Cost Of Coal Products And Services CostOfCoalProductsAndServices	28749000	USD
CY2016Q2	us-gaap	Cost Of Coal Products And Services CostOfCoalProductsAndServices	5437000	USD
	us-gaap	Cost Of Coal Products And Services CostOfCoalProductsAndServices	22470000	USD
CY2015Q2	us-gaap	Cost Of Services CostOfServices	41000	USD
	us-gaap	Cost Of Services CostOfServices	278000	USD
CY2016Q2	us-gaap	Cost Of Services CostOfServices	255000	USD
	us-gaap	Cost Of Services CostOfServices	396000	USD
CY2015Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	2137000	USD
CY2016Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	1254000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	767000	USD
CY2016Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	605000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	682000	USD
CY2016Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	305000	USD
CY2015Q4	us-gaap	Deposit Assets DepositAssets	414000	USD
CY2016Q2	us-gaap	Deposit Assets DepositAssets	264000	USD
CY2015Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	573000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1104000	USD
CY2016Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	223000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	454000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1104000	USD
CY2015Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	270000	USD
CY2016Q2	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	35000	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2015Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-72000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5800000	USD
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3413000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P8M23D
CY2016Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	2012000	USD
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	19000	USD
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5900000	USD
CY2015Q2	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
CY2016Q2	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	2078000	USD
CY2015Q4	us-gaap	Equity Method Investments EquityMethodInvestments	17232000	USD
CY2016Q2	us-gaap	Equity Method Investments EquityMethodInvestments	3081000	USD
	us-gaap	Extended Product Warranty Accrual Period Increase Decrease ExtendedProductWarrantyAccrualPeriodIncreaseDecrease	-411000	USD
CY2015Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	151000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1019000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1503000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3385000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1346000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2092000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12384000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18472000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7959000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	12388000	USD
CY2015Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4860000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5174000	USD
CY2016Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	13754000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19331000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	107000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	152000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	146000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2713000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2910000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7625000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	627000	USD
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	226000	USD
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-1473000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1651000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1596000	USD
	us-gaap	Increase Decrease In Cost In Excess Of Billing On Uncompleted Contract IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract	9420000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-231000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2630000	USD
	us-gaap	Increase Decrease In Cost In Excess Of Billing On Uncompleted Contract IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract	20910000	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	1496000	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	618000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1348000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-101000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-806000	USD
	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	1200000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	709000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-1089000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	19000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1336000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	460000	USD
	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	550000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	1794000	USD
	us-gaap	Interest Expense InterestExpense	3569000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	1573000	USD
	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.05
	us-gaap	Interest Expense InterestExpense	3537000	USD
CY2015Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	0	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	0	USD
CY2016Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1215000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	2112000	USD
CY2015Q2	us-gaap	Interest Expense Other InterestExpenseOther	69000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	83000	USD
CY2016Q2	us-gaap	Interest Expense Other InterestExpenseOther	4000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	17000	USD
	us-gaap	Interest Paid InterestPaid	2993000	USD
	us-gaap	Interest Paid InterestPaid	1436000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	189000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	187000	USD
CY2015Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	18000	USD
CY2016Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	95000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	118000	USD
CY2015Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	9746000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	14657000	USD
CY2016Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3956000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7759000	USD
CY2015Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	601000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1232000	USD
CY2016Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	632000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1026000	USD
CY2015Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	12034000	USD
CY2016Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	11163000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	85753000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	47099000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60775000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36608000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	50092000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	30270000	USD
CY2013Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	10000000	USD
CY2015Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	13512000	USD
CY2016Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2015Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	336000	USD
CY2016Q2	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1276000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15160000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	296000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13788000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7984000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-12447000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18579000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	7860000	USD
	us-gaap	Net Income Loss NetIncomeLoss	12236000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12317000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18364000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7777000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12127000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	899000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	11156000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5394000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6203000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12571000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20333000	USD
CY2015Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1837000	USD
CY2016Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2015Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1837000	USD
CY2016Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0	USD
CY2015Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	15349000	USD
CY2016Q2	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	0	USD
CY2015Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	13512000	USD
CY2016Q2	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	0	USD
CY2015Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	32673000	USD
	us-gaap	Operating Expenses OperatingExpenses	61327000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	13563000	USD
	us-gaap	Operating Expenses OperatingExpenses	39231000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-17778000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24675000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4612000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7945000	USD
CY2015Q4	us-gaap	Other Assets OtherAssets	2696000	USD
CY2016Q2	us-gaap	Other Assets OtherAssets	3714000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2306000	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1781000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2696000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3714000	USD
CY2015Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1941000	USD
CY2016Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	635000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7395000	USD
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7012000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5372000	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2871000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	87000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-525000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-535000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	688000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	34000	USD
CY2015Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	316000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	684000	USD
CY2016Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	125000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	320000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	579000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2124000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	230000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	223000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	380000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	111000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2306000	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1781000	USD
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2117000	USD
CY2016Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1287000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	4730000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	14875000	USD
	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	-262000	USD
	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	-85000	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	336000	USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	1773000	USD
CY2015Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1197000	USD
CY2016Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	959000	USD
CY2015Q2	us-gaap	Professional Fees ProfessionalFees	4387000	USD
	us-gaap	Professional Fees ProfessionalFees	8122000	USD
CY2016Q2	us-gaap	Professional Fees ProfessionalFees	1982000	USD
	us-gaap	Professional Fees ProfessionalFees	4965000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2040000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1218000	USD
CY2015Q4	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	2980000	USD
CY2016Q2	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	2362000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	13234000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1014000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1246000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	13250000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1860000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3110000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	-345000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	-143000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	728000	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4469000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	10980000	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6700000	USD
CY2015Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	41	employee
	us-gaap	Share Based Compensation ShareBasedCompensation	1543000	USD
CY2016Q2	us-gaap	Share Price SharePrice	4.25
	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	45	employee
CY2016Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	19	employee
	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	22	employee
CY2015Q2	us-gaap	Restructuring Charges RestructuringCharges	5565000	USD
	us-gaap	Restructuring Charges RestructuringCharges	6043000	USD
CY2016Q2	us-gaap	Restructuring Charges RestructuringCharges	784000	USD
	us-gaap	Restructuring Charges RestructuringCharges	1067000	USD
CY2015Q2	us-gaap	Restructuring Costs RestructuringCosts	5563000	USD
	us-gaap	Restructuring Costs RestructuringCosts	6031000	USD
CY2016Q2	us-gaap	Restructuring Costs RestructuringCosts	784000	USD
	us-gaap	Restructuring Costs RestructuringCosts	1067000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-141029000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128793000	USD
CY2015Q2	us-gaap	Revenues Revenues	14895000	USD
	us-gaap	Revenues Revenues	36652000	USD
CY2016Q2	us-gaap	Revenues Revenues	8951000	USD
	us-gaap	Revenues Revenues	31286000	USD
CY2015Q2	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	2299000	USD
	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	4493000	USD
CY2016Q2	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	669000	USD
	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	1859000	USD
CY2015Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	343000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	617000	USD
CY2016Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	613000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1047000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5459000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	200000	USD
CY2015Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	12676000	USD
CY2016Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2015Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1197000	USD
CY2016Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	959000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	173000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-24978000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	-10491000	USD
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	521000	USD
CY2016Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	583000	USD
CY2015Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-130000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-215000	USD
CY2016Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	83000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	109000	USD
CY2015Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	312000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	309000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21715000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21728000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22187000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22204000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21715000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21728000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21875000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21895000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's certificates of deposits and virtually all of the Company's restricted and unrestricted cash accounts are at </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> financial institutions. If those institutions were to be unable to perform their obligations, the Company would be at risk regarding the amount of cash and investments in excess of the Federal Deposit Insurance Corporation limits (</font><font style="font-family:inherit;font-size:10pt;">$250 thousand</font><font style="font-family:inherit;font-size:10pt;">) that would be returned to the Company. </font></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain balances have been reclassified from the prior year to conform to the current year presentation.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to makes estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. There have been no changes in the Company’s critical accounting estimates from those that were disclosed in the Company’s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. Actual results could differ from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001515156-16-000143-index-headers.html	Edgar Link	pending
0001515156-16-000143-index.html	Edgar Link	pending
0001515156-16-000143.txt	Edgar Link	pending
0001515156-16-000143-xbrl.zip	Edgar Link	pending
ades-20160630.xml	Edgar Link	completed
ades-20160630.xsd	Edgar Link	pending
ades-20160630x10q.htm	Edgar Link	pending
ades-20160630_cal.xml	Edgar Link	unprocessable
ades-20160630_def.xml	Edgar Link	unprocessable
ades-20160630_lab.xml	Edgar Link	unprocessable
ades-20160630_pre.xml	Edgar Link	unprocessable
exhibit10220160630finals.htm	Edgar Link	pending
exhibit10220160630finals001.jpg	Edgar Link	pending
exhibit10220160630finals002.jpg	Edgar Link	pending
exhibit10220160630finals003.jpg	Edgar Link	pending
exhibit10220160630finals004.jpg	Edgar Link	pending
exhibit10220160630finals005.jpg	Edgar Link	pending
exhibit10220160630finals006.jpg	Edgar Link	pending
exhibit10220160630finals007.jpg	Edgar Link	pending
exhibit10220160630finals008.jpg	Edgar Link	pending
exhibit10220160630finals009.jpg	Edgar Link	pending
exhibit10220160630finals010.jpg	Edgar Link	pending
exhibit10220160630finals011.jpg	Edgar Link	pending
exhibit10220160630finals012.jpg	Edgar Link	pending
exhibit10220160630finals013.jpg	Edgar Link	pending
exhibit10220160630finals014.jpg	Edgar Link	pending
exhibit10220160630finals015.jpg	Edgar Link	pending
exhibit10220160630finals016.jpg	Edgar Link	pending
exhibit10220160630finals017.jpg	Edgar Link	pending
exhibit10220160630finals018.jpg	Edgar Link	pending
exhibit10220160630finals019.jpg	Edgar Link	pending
exhibit10220160630finals020.jpg	Edgar Link	pending
exhibit10220160630finals021.jpg	Edgar Link	pending
exhibit10220160630finals022.jpg	Edgar Link	pending
exhibit10220160630finals023.jpg	Edgar Link	pending
exhibit10220160630finals024.jpg	Edgar Link	pending
exhibit10220160630finals025.jpg	Edgar Link	pending
exhibit10220160630finals026.jpg	Edgar Link	pending
exhibit10220160630finals027.jpg	Edgar Link	pending
exhibit10220160630finals028.jpg	Edgar Link	pending
exhibit10220160630finals029.jpg	Edgar Link	pending
exhibit10220160630finals030.jpg	Edgar Link	pending
exhibit10220160630finals031.jpg	Edgar Link	pending
exhibit10220160630finals032.jpg	Edgar Link	pending
exhibit10220160630finals033.jpg	Edgar Link	pending
exhibit10220160630finals034.jpg	Edgar Link	pending
exhibit10220160630finals035.jpg	Edgar Link	pending
exhibit10220160630finals036.jpg	Edgar Link	pending
exhibit10220160630finals037.jpg	Edgar Link	pending
exhibit10220160630finals038.jpg	Edgar Link	pending
exhibit10220160630finals039.jpg	Edgar Link	pending
exhibit10220160630finals040.jpg	Edgar Link	pending
exhibit10220160630finals041.jpg	Edgar Link	pending
exhibit10220160630finals042.jpg	Edgar Link	pending
exhibit10220160630finals043.jpg	Edgar Link	pending
exhibit10220160630finals044.jpg	Edgar Link	pending
exhibit10220160630finals045.jpg	Edgar Link	pending
exhibit10220160630finals046.jpg	Edgar Link	pending
exhibit1037thamendand8th.htm	Edgar Link	pending
exhibit1037thamendand8th001.jpg	Edgar Link	pending
exhibit1037thamendand8th002.jpg	Edgar Link	pending
exhibit1037thamendand8th003.jpg	Edgar Link	pending
exhibit1037thamendand8th004.jpg	Edgar Link	pending
exhibit1037thamendand8th005.jpg	Edgar Link	pending
exhibit1037thamendand8th006.jpg	Edgar Link	pending
exhibit1037thamendand8th007.jpg	Edgar Link	pending
exhibit1037thamendand8th008.jpg	Edgar Link	pending
exhibit1037thamendand8th009.jpg	Edgar Link	pending
exhibit1037thamendand8th010.jpg	Edgar Link	pending
exhibit1037thamendand8th011.jpg	Edgar Link	pending
exhibit1037thamendand8th012.jpg	Edgar Link	pending
exhibit1037thamendand8th013.jpg	Edgar Link	pending
exhibit1037thamendand8th014.jpg	Edgar Link	pending
exhibit1037thamendand8th015.jpg	Edgar Link	pending
exhibit1037thamendand8th016.jpg	Edgar Link	pending
exhibit1037thamendand8th017.jpg	Edgar Link	pending
exhibit1037thamendand8th018.jpg	Edgar Link	pending
exhibit1037thamendand8th019.jpg	Edgar Link	pending
exhibit1037thamendand8th020.jpg	Edgar Link	pending
exhibit1037thamendand8th021.jpg	Edgar Link	pending
exhibit1037thamendand8th022.jpg	Edgar Link	pending
exhibit1037thamendand8th023.jpg	Edgar Link	pending
exhibit1037thamendand8th024.jpg	Edgar Link	pending
exhibit1037thamendand8th025.jpg	Edgar Link	pending
exhibit1037thamendand8th026.jpg	Edgar Link	pending
exhibit1037thamendand8th027.jpg	Edgar Link	pending
exhibit1037thamendand8th028.jpg	Edgar Link	pending
exhibit1037thamendand8th029.jpg	Edgar Link	pending
exhibit1037thamendand8th030.jpg	Edgar Link	pending
exhibit1037thamendand8th031.jpg	Edgar Link	pending
exhibit1037thamendand8th032.jpg	Edgar Link	pending
exhibit1037thamendand8th033.jpg	Edgar Link	pending
exhibit1037thamendand8th034.jpg	Edgar Link	pending
exhibit1037thamendand8th035.jpg	Edgar Link	pending
exhibit1037thamendand8th036.jpg	Edgar Link	pending
exhibit1037thamendand8th037.jpg	Edgar Link	pending
exhibit1037thamendand8th038.jpg	Edgar Link	pending
exhibit1037thamendand8th039.jpg	Edgar Link	pending
exhibit1037thamendand8th040.jpg	Edgar Link	pending
exhibit1037thamendand8th041.jpg	Edgar Link	pending
exhibit1037thamendand8th042.jpg	Edgar Link	pending
exhibit1037thamendand8th043.jpg	Edgar Link	pending
exhibit1037thamendand8th044.jpg	Edgar Link	pending
exhibit1037thamendand8th045.jpg	Edgar Link	pending
exhibit1037thamendand8th046.jpg	Edgar Link	pending
exhibit1037thamendand8th047.jpg	Edgar Link	pending
exhibit1037thamendand8th048.jpg	Edgar Link	pending
exhibit1037thamendand8th049.jpg	Edgar Link	pending
exhibit1037thamendand8th050.jpg	Edgar Link	pending
exhibit1037thamendand8th051.jpg	Edgar Link	pending
exhibit1037thamendand8th052.jpg	Edgar Link	pending
exhibit1037thamendand8th053.jpg	Edgar Link	pending
exhibit1037thamendand8th054.jpg	Edgar Link	pending
exhibit1037thamendand8th055.jpg	Edgar Link	pending
exhibit1037thamendand8th056.jpg	Edgar Link	pending
exhibit1037thamendand8th057.jpg	Edgar Link	pending
exhibit1037thamendand8th058.jpg	Edgar Link	pending
exhibit1037thamendand8th059.jpg	Edgar Link	pending
exhibit1037thamendand8th060.jpg	Edgar Link	pending
exhibit1037thamendand8th061.jpg	Edgar Link	pending
exhibit1037thamendand8th062.jpg	Edgar Link	pending
exhibit1037thamendand8th063.jpg	Edgar Link	pending
exhibit1037thamendand8th064.jpg	Edgar Link	pending
exhibit1037thamendand8th065.jpg	Edgar Link	pending
exhibit1037thamendand8th066.jpg	Edgar Link	pending
exhibit1037thamendand8th067.jpg	Edgar Link	pending
exhibit1037thamendand8th068.jpg	Edgar Link	pending
exhibit1037thamendand8th069.jpg	Edgar Link	pending
exhibit1037thamendand8th070.jpg	Edgar Link	pending
exhibit1037thamendand8th071.jpg	Edgar Link	pending
exhibit1037thamendand8th072.jpg	Edgar Link	pending
exhibit1037thamendand8th073.jpg	Edgar Link	pending
exhibit1037thamendand8th074.jpg	Edgar Link	pending
exhibit1037thamendand8th075.jpg	Edgar Link	pending
exhibit1037thamendand8th076.jpg	Edgar Link	pending
exhibit1037thamendand8th077.jpg	Edgar Link	pending
exhibit1037thamendand8th078.jpg	Edgar Link	pending
exhibit1037thamendand8th079.jpg	Edgar Link	pending
exhibit1037thamendand8th080.jpg	Edgar Link	pending
exhibit1037thamendand8th081.jpg	Edgar Link	pending
exhibit1037thamendand8th082.jpg	Edgar Link	pending
exhibit1037thamendand8th083.jpg	Edgar Link	pending
exhibit1037thamendand8th084.jpg	Edgar Link	pending
exhibit1037thamendand8th085.jpg	Edgar Link	pending
exhibit1037thamendand8th086.jpg	Edgar Link	pending
exhibit1037thamendand8th087.jpg	Edgar Link	pending
exhibit1037thamendand8th088.jpg	Edgar Link	pending
exhibit1037thamendand8th089.jpg	Edgar Link	pending
exhibit1037thamendand8th090.jpg	Edgar Link	pending
exhibit1037thamendand8th091.jpg	Edgar Link	pending
exhibit1037thamendand8th092.jpg	Edgar Link	pending
exhibit1037thamendand8th093.jpg	Edgar Link	pending
exhibit1037thamendand8th094.jpg	Edgar Link	pending
exhibit1037thamendand8th095.jpg	Edgar Link	pending
exhibit1037thamendand8th096.jpg	Edgar Link	pending
exhibit1037thamendand8th097.jpg	Edgar Link	pending
exhibit1037thamendand8th098.jpg	Edgar Link	pending
exhibit1037thamendand8th099.jpg	Edgar Link	pending
exhibit1037thamendand8th100.jpg	Edgar Link	pending
exhibit1037thamendand8th101.jpg	Edgar Link	pending
exhibit1037thamendand8th102.jpg	Edgar Link	pending
exhibit1037thamendand8th103.jpg	Edgar Link	pending
exhibit1037thamendand8th104.jpg	Edgar Link	pending
exhibit1037thamendand8th105.jpg	Edgar Link	pending
exhibit1037thamendand8th106.jpg	Edgar Link	pending
exhibit1037thamendand8th107.jpg	Edgar Link	pending
exhibit1037thamendand8th108.jpg	Edgar Link	pending
exhibit1037thamendand8th109.jpg	Edgar Link	pending
exhibit1037thamendand8th110.jpg	Edgar Link	pending
exhibit1037thamendand8th111.jpg	Edgar Link	pending
exhibit1037thamendand8th112.jpg	Edgar Link	pending
exhibit1037thamendand8th113.jpg	Edgar Link	pending
exhibit1037thamendand8th114.jpg	Edgar Link	pending
exhibit1037thamendand8th115.jpg	Edgar Link	pending
exhibit1037thamendand8th116.jpg	Edgar Link	pending
exhibit1037thamendand8th117.jpg	Edgar Link	pending
exhibit1037thamendand8th118.jpg	Edgar Link	pending
exhibit1037thamendand8th119.jpg	Edgar Link	pending
exhibit1037thamendand8th120.jpg	Edgar Link	pending
exhibit1037thamendand8th121.jpg	Edgar Link	pending
exhibit1037thamendand8th122.jpg	Edgar Link	pending
exhibit1037thamendand8th123.jpg	Edgar Link	pending
exhibit1037thamendand8th124.jpg	Edgar Link	pending
exhibit1037thamendand8th125.jpg	Edgar Link	pending
exhibit1037thamendand8th126.jpg	Edgar Link	pending
exhibit1037thamendand8th127.jpg	Edgar Link	pending
exhibit1037thamendand8th128.jpg	Edgar Link	pending
exhibit31120160630-10q.htm	Edgar Link	pending
exhibit32120160630-10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARQ
Arq, Inc. Stock $arq

2016 Q2 Form 10-Q Financial Statement

#000151515616000143 Filed on August 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARQ Arq, Inc. Stock $arq

2016 Q2 Form 10-Q Financial Statement

#000151515616000143 Filed on August 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARQ
Arq, Inc. Stock $arq